O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+9.5%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$8.33B
AUM Growth
+$8.33B
(+4%)
Cap. Flow
-$6.28M
Cap. Flow
% of AUM
-0.08%
Top 10 Holdings %
Top 10 Hldgs %
34.18%
Holding
150
New
16
Increased
26
Reduced
35
Closed
6
Top Buys
| 1 |
TCDA
Tricida, Inc. Common Stock
TCDA
|
$326M |
| 2 |
Elevance Health
ELV
|
$127M |
| 3 |
AGN
Allergan plc
AGN
|
$98.8M |
| 4 |
Dentsply Sirona
XRAY
|
$94.9M |
| 5 |
Inspire Medical Systems
INSP
|
$87.2M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$204M |
| 2 |
ARMO
ARMO BioSciences, Inc. Common Stock
ARMO
|
$154M |
| 3 |
AbbVie
ABBV
|
$145M |
| 4 |
Tenet Healthcare
THC
|
$128M |
| 5 |
Bristol-Myers Squibb
BMY
|
$71.7M |
Sector Composition
| 1 | Healthcare | 94.35% |
| 2 | Financials | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVS
26
DELISTED
Clovis Oncology, Inc.
CLVS
| $106M | 1.26% | 2,330,870 | – | – |
|
|
27
Dentsply Sirona
XRAY
$2.85B
| $105M | 1.25% | 2,393,500 +2,168,500 | +964% | +$94.9M |
|
|
NVRO
28
DELISTED
NEVRO CORP.
NVRO
| $101M | 1.2% | 1,260,091 | – | – |
|
|
BOLD
29
DELISTED
Audentes Therapeutics, Inc
BOLD
| $99.9M | 1.19% | 2,615,000 -907,100 | -26% | -$34.7M |
|
|
LOXO
30
DELISTED
Loxo Oncology, Inc
LOXO
| $93.3M | 1.11% | 538,000 -403,000 | -43% | -$69.9M |
|
31
Select Medical
SEM
$1.61B
| $92.1M | 1.1% | 5,074,200 | – | – |
|
32
Johnson & Johnson
JNJ
$427B
| $91.7M | 1.09% | 756,000 +290,700 | +62% | +$35.3M |
|
|
33
Inspire Medical Systems
INSP
$2.77B
| $87.2M | 1.04% | +2,444,221 | New | +$87.2M |
|
|
ARRY
34
DELISTED
Array Biopharma Inc
ARRY
| $82.2M | 0.98% | 4,900,900 | – | – |
|
35
Illumina
ILMN
$15.8B
| $79.5M | 0.95% | 284,500 | – | – |
|
|
DCPH
36
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $78.9M | 0.94% | 2,005,700 +472,800 | +31% | +$18.6M |
|
|
BLUE
37
DELISTED
bluebird bio
BLUE
| $76.6M | 0.91% | 488,200 +142,600 | +41% | +$22.4M |
|
38
Iovance Biotherapeutics
IOVA
$807M
| $71M | 0.85% | 5,548,326 | – | – |
|
39
Insmed
INSM
$28.8B
| $69.2M | 0.83% | 2,927,891 | – | – |
|
40
Corvus Pharmaceuticals
CRVS
$428M
| $65.5M | 0.78% | 5,967,584 | – | – |
|
|
VRAY
41
DELISTED
ViewRay, Inc.
VRAY
| $65.5M | 0.78% | 9,458,567 | – | – |
|
42
Acadia Pharmaceuticals
ACAD
$4.38B
| $65.4M | 0.78% | 4,282,400 +941,700 | +28% | +$14.4M |
|
43
Rhythm Pharmaceuticals
RYTM
$6.85B
| $64.6M | 0.77% | 2,065,000 -836,295 | -29% | -$26.1M |
|
|
SHPG
44
DELISTED
Shire pic
SHPG
| $60.2M | 0.72% | 356,608 -293,700 | -45% | -$49.6M |
|
45
Sarepta Therapeutics
SRPT
$1.78B
| $59.8M | 0.71% | 452,600 +131,000 | +41% | +$17.3M |
|
46
Ironwood Pharmaceuticals
IRWD
$214M
| $56M | 0.67% | 2,929,250 | – | – |
|
47
Intuitive Surgical
ISRG
$170B
| $52.9M | 0.63% | 110,500 +8,500 | +8% | +$4.07M |
|
48
Universal Health Services
UHS
$11.6B
| $51.6M | 0.62% | 463,300 -309,600 | -40% | -$34.5M |
|
49
Xtant Medical Holdings
XTNT
$83.3M
| $51.1M | 0.61% | 9,207,012 | – | – |
|
50
Heron Therapeutics
HRTX
$207M
| $51.1M | 0.61% | 1,315,100 +175,300 | +15% | +$6.81M |
|